| __timestamp | Dr. Reddy's Laboratories Limited | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 21226345 |
| Thursday, January 1, 2015 | 62786000000 | 139626 |
| Friday, January 1, 2016 | 62427000000 | 93831530 |
| Sunday, January 1, 2017 | 62453000000 | 79419009 |
| Monday, January 1, 2018 | 65724000000 | 368673 |
| Tuesday, January 1, 2019 | 70421000000 | 477121 |
| Wednesday, January 1, 2020 | 80591000000 | 1895029 |
| Friday, January 1, 2021 | 86645000000 | 8034589 |
| Saturday, January 1, 2022 | 100551000000 | 20443000 |
| Sunday, January 1, 2023 | 42907000000 | 33745000 |
| Monday, January 1, 2024 | 115557000000 |
Igniting the spark of knowledge
In the dynamic world of pharmaceuticals, understanding cost structures is crucial. This chart compares the cost of revenue trends for Intra-Cellular Therapies, Inc. and Dr. Reddy's Laboratories Limited from 2014 to 2023. Dr. Reddy's Laboratories, a global player, consistently shows a robust cost of revenue, peaking in 2024 with a 15% increase from 2022. In contrast, Intra-Cellular Therapies, a niche biotech firm, exhibits a more volatile pattern, with costs fluctuating significantly over the years. Notably, 2023 saw a 65% rise in their cost of revenue compared to 2022, highlighting their expanding operations. However, data for 2024 is missing, leaving room for speculation. This comparison underscores the diverse financial landscapes within the pharmaceutical industry, where scale and specialization drive distinct cost dynamics.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Intra-Cellular Therapies, Inc.
Cost Insights: Breaking Down United Therapeutics Corporation and Dr. Reddy's Laboratories Limited's Expenses
Cost of Revenue Trends: Incyte Corporation vs Intra-Cellular Therapies, Inc.
Cost of Revenue Trends: Incyte Corporation vs Dr. Reddy's Laboratories Limited
Analyzing Cost of Revenue: Intra-Cellular Therapies, Inc. and Lantheus Holdings, Inc.
Cost Insights: Breaking Down Intra-Cellular Therapies, Inc. and Bausch Health Companies Inc.'s Expenses
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs Amphastar Pharmaceuticals, Inc.
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Halozyme Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs MorphoSys AG
Dr. Reddy's Laboratories Limited vs Amphastar Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Celldex Therapeutics, Inc.